Dr Imran Mohammed
Lecturer
School of Optometry and Vision Sciences
- MohammedI5@cardiff.ac.uk
- +44 29208 75347
- Optometry and Vision Sciences, Room 3.04, Maindy Road, Cathays, Cardiff, CF24 4HQ
- Available for postgraduate supervision
Overview
I am currently a Lecturer (Assistant Professor) within the School of Optometry and Vision Sciences, College of Biomedical and Life Sciences.
Microbial keratitis (also known as infectious keratitis) is the leading cause of monocular blindness worldwide. The main focus of my laboratory is to investigate the host-pathogen interactions during corneal infection and develop novel immunomodulatory and anti-infective therapeutics for the prevention of blindness.
I have over 13 years of academic research experience in the preclinical development of novel therapeutics for corneal and retinal blindness.
I have published 38 research articles in scientific journals, attracted >£850,000 in research funding, received multiple awards and prizes, was invited as a keynote speaker at numerous conferences/meetings, and developed intellectual property materials.
Publication
2024
- Hammoudeh, Y. et al. 2024. Microbiological culture versus 16S/18S rRNA gene PCR-sanger sequencing for infectious keratitis: a three-arm, diagnostic cross-sectional study. Frontiers in Medicine 11, article number: 1393832. (10.3389/fmed.2024.1393832)
2023
- Dua, H. S., Freitas, R., Sadek, Y., Ting, D. S., Nubile, M., Mohammed, I. and Said, D. G. 2023. An approach to reduce Descemet's membrane scrolling: Relevance to Descemet's membrane endothelial keratoplasty (DMEK). Indian Journal of Ophthalmology 71(9), pp. 3178-3185. (10.4103/IJO.IJO_1531_23)
2022
- Deshmukh, R., Ting, D. S. J., Elsahn, A., Mohammed, I., Said, D. G. and Dua, H. S. 2022. Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases. British Journal of Ophthalmology 106, pp. 1087-1092. (10.1136/bjophthalmol-2020-317907)
- Ting, D., Mohammed, I., Lakshminarayanan, R., Beuerman, R. W. and Dua, H. S. 2022. Host defense peptides at the ocular surface: roles in health and major diseases, and therapeutic potentials.. Frontiers in Medicine 9, article number: 835843. (10.3389/fmed.2022.835843)
- Ali, W., Elsahn, A., Ting, D. S., Dua, H. S. and Mohammed, I. 2022. Host defence peptides: a potent alternative to combat antimicrobial resistance in the era of the covid-19 pandemic.. Antibiotics (Basel, Switzerland) 11(4), article number: 475. (10.3390/antibiotics11040475)
2021
- Shu Jeng Ting, D. et al. 2021. Evaluation of host defense peptide (CaD23)-antibiotic interaction and mechanism of action: insights from experimental and molecular dynamics simulations studies. Frontiers in Pharmacology 12, article number: 731499. (10.3389/fphar.2021.731499)
- Shu Jeng Ting, D. et al. 2021. Hybrid derivative of cathelicidin and human beta defensin-2 against Gram-positive bacteria: A novel approach for the treatment of bacterial keratitis. Scientific Reports 11, article number: 18304. (10.1038/s41598-021-97821-3)
- Akhtar, R., Tahir, H., Stewart, E., Wei, R., Mohammed, I. and Amoaku, W. M. 2021. Toll-like receptor signalling pathways regulate hypoxic stress induced fibroblast growth factor but not vascular endothelial growth factor-a in human microvascular endothelial cells. International Journal of Translational Medicine 1(1), pp. 25-38. (10.3390/ijtm1010003)
2020
- Mohammed, I., Kulkarni, B., Faraj, L. A., Abbas, A., Dua, H. S. and King, A. J. 2020. Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: a two-year randomised evaluation study. Clinical & experimental ophthalmology 48(7), pp. 973-982. (10.1111/ceo.13814)
- Mohammed, I. et al. 2020. Antimicrobial peptides in human corneal tissue of patients with fungal keratitis. British Journal of Ophthalmology 105, pp. 1172-1177. (10.1136/bjophthalmol-2020-316329)
- Ting, D. S. J., Beuerman, R. W., Dua, H. S., Lakshminarayanan, R. and Mohammed, I. 2020. Strategies in translating the therapeutic potentials of host defense peptides. Frontiers in Immunology 11, article number: 983. (10.3389/fimmu.2020.00983)
2019
- Al-Aqaba, M. A., Dhillon, V. K., Mohammed, I., Said, D. G. and Dua, H. S. 2019. Corneal nerves in health and disease. Progress in Retinal and Eye Research 73, article number: 100762. (10.1016/j.preteyeres.2019.05.003)
- Mohammed, I., Said, D. G., Nubile, M., Mastropasqua, L. and Dua, H. S. 2019. Cathelicidin-derived synthetic peptide improves therapeutic potential of vancomycin against pseudomonas aeruginosa. Frontiers in Microbiology 10, article number: 2190. (10.3389/fmicb.2019.02190)
- Al-Aqaba, M. A., Anis, F. S., Mohammed, I., Yapa, A. D. S., Amoaku, W. M. and Dua, H. S. S. 2019. In vivo confocal microscopy features and clinicohistological correlation of limbal nerve corpuscles. British Journal of Ophthalmology 105, pp. 285-289. (10.1136/bjophthalmol-2018-313199)
- Ghoz, N., Ross, A. R., Mohammed, I., Hogan, E., Said, D. G. and Dua, H. S. 2019. Management of primary pterygium with intra-lesional injection of 5 flurouracil and bevacizumab (Avastin).. Eye 33, pp. 1776-1783. (10.1038/s41433-019-0493-0)
- Song, D. et al. 2019. Complement factor h mutation w1206r causes retinal thrombosis and ischemic retinopathy in mice. The American Journal of Pathology 189(4), pp. 826-838. (10.1016/j.ajpath.2019.01.009)
2018
- Said, D. G., Ross, A. R., Messina, M., Mohammed, I. and Dua, H. S. 2018. Localised corneal haze and scarring following pulsed accelerated collagen cross-linking for keratoconus. Eye (Basingstoke) 33(1), pp. 167-168. (10.1038/s41433-018-0211-3)
- Song, D. et al. 2018. Retinal basal laminar deposits in complement fh/fp mouse model of dense deposit disease. Investigative Ophthalmology & Visual Science 54, pp. 3405-3415. (10.1167/iovs.18-24133)
- Mohammed, I., Ross, A. R., Britton, J. O., Said, D. G. and Dua, H. S. 2018. Elastin content and distribution in endothelial keratoplasty tissue determines direction of scrolling. American Journal of Ophthalmology 194, pp. 16-25. (10.1016/j.ajo.2018.07.001)
2017
- Al-Aqaba, M. ., Anis, F. S., Mohammed, I. and Dua, H. S. 2017. Nerve terminals at the human corneoscleral limbus. British Journal of Ophthalmology 102(4), pp. 556-561. (10.1136/bjophthalmol-2017-311146)
- Mohammed, I., Said, D. G. and Dua, H. S. 2017. Human antimicrobial peptides in ocular surface defense. Progress in Retinal and Eye Research 61, pp. 1-22. (10.1016/j.preteyeres.2017.03.004)
- Ueda, Y. et al. 2017. Murine systemic thrombophilia and hemolytic uremic syndrome from a factor h point mutation. Blood 129(9), pp. 1184-1196. (10.1182/blood-2016-07-728253)
2014
- Haris, M. et al. 2014. In vivo magnetic resonance imaging of tumor protease activity. Scientific Reports 4, article number: 6081. (10.1038/srep06081)
- Dua, H. S., Otri, A., Hopkinson, A. and Mohammed, I. 2014. In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American Ophthalmological Society thesis).. Transactions of the American Ophthalmological Society 112, pp. 50-73.
2013
- Barata, L., Miwa, T., Sato, S., Kim, D., Mohammed, I. and Song, W. C. 2013. Deletion of crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack. The Journal of Immunology 190(6), pp. 2886-2895. (10.4049/jimmunol.1202536)
2012
- Otri, A. M., Mohammed, I., Al-Aqaba, M. A., Fares, U., Peng, C., Hopkinson, A. and Dua, H. S. 2012. Variable expression of human beta defensins 3 and 9 at the human ocular surface in infectious keratitis. Investigative Ophthalmology and Visual Science 53(2), pp. 757-761. (10.1167/iovs.11-8467)
2011
- Mohammed, I. et al. 2011. Increased expression of hepcidin and toll-like receptors 8 and 10 in viral keratitis. Cornea 30(8), pp. 899-904. (10.1097/ICO.0b013e31820126e5)
- Kulkarni, B., Mohammed, I., Hopkinson, A. and Dua, H. S. 2011. Validation of endogenous control genes for gene expression studies on human ocular surface epithelium. PLoS ONE 6(8), article number: 22301. (10.1371/journal.pone.0022301)
- Mohammed, I., Yeung, A., Abedin, A., Hopkinson, A. and Dua, H. S. 2011. Signalling pathways involved in ribonuclease-7 expression. Cellular and Molecular Life Sciences 68(11), pp. 1941-1952. (10.1007/s00018-010-0540-2)
2010
- Mohammed, I., Suleman, H., Otri, A. M., Kulkarni, B. B., Chen, P., Hopkinson, A. and Dua, H. S. 2010. Localization and gene expression of human β-defensin 9 at the human ocular surface epithelium. Investigative Ophthalmology and Visual Science 51(9), pp. 4677-4682. (10.1167/iovs.10-5334)
- Kulkarni, B. B. et al. 2010. Comparative transcriptional profiling of the limbal epithelial crypt demonstrates its putative stem cell niche characteristics. BMC Genomics 11(1), article number: 526. (10.1186/1471-2164-11-526)
- Otri, A. M., Mohammed, I., Abedin, A., Cao, Z., Hopkinson, A., Panjwani, N. and Dua, H. S. 2010. Antimicrobial peptides expression by ocular surface cells in response to acanthamoeba castellanii: an in vitro study. British Journal of Ophthalmology 94(11), pp. 1523-1527. (10.1136/bjo.2009.178236)
2009
- Gicquel, J. et al. 2009. Epidermal growth factor variations in amniotic membrane used for ex vivo tissue constructs. Tissue Engineering - Part A 15(8), pp. 1919-1927. (10.1089/ten.tea.2008.0432)
- Yeung, A., Tint, N., Kulkarni, B., Mohammed, I., Suleman, H., Hopkinson, A. and Dua, H. S. 2009. Infant limbus: an immunohistological study. Experimental Eye Research 88(6), pp. 1161-1164. (10.1016/j.exer.2008.12.014)
2008
- Abedin, A., Mohammed, I., Hopkinson, A. and Dua, H. S. 2008. A novel antimicrobial peptide on the ocular surface shows decreased expression in inflammation and infection. Investigative Ophthalmology and Visual Science 49(1), pp. 28-33. (10.1167/iovs.07-0645)
Articles
- Hammoudeh, Y. et al. 2024. Microbiological culture versus 16S/18S rRNA gene PCR-sanger sequencing for infectious keratitis: a three-arm, diagnostic cross-sectional study. Frontiers in Medicine 11, article number: 1393832. (10.3389/fmed.2024.1393832)
- Dua, H. S., Freitas, R., Sadek, Y., Ting, D. S., Nubile, M., Mohammed, I. and Said, D. G. 2023. An approach to reduce Descemet's membrane scrolling: Relevance to Descemet's membrane endothelial keratoplasty (DMEK). Indian Journal of Ophthalmology 71(9), pp. 3178-3185. (10.4103/IJO.IJO_1531_23)
- Deshmukh, R., Ting, D. S. J., Elsahn, A., Mohammed, I., Said, D. G. and Dua, H. S. 2022. Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases. British Journal of Ophthalmology 106, pp. 1087-1092. (10.1136/bjophthalmol-2020-317907)
- Ting, D., Mohammed, I., Lakshminarayanan, R., Beuerman, R. W. and Dua, H. S. 2022. Host defense peptides at the ocular surface: roles in health and major diseases, and therapeutic potentials.. Frontiers in Medicine 9, article number: 835843. (10.3389/fmed.2022.835843)
- Ali, W., Elsahn, A., Ting, D. S., Dua, H. S. and Mohammed, I. 2022. Host defence peptides: a potent alternative to combat antimicrobial resistance in the era of the covid-19 pandemic.. Antibiotics (Basel, Switzerland) 11(4), article number: 475. (10.3390/antibiotics11040475)
- Shu Jeng Ting, D. et al. 2021. Evaluation of host defense peptide (CaD23)-antibiotic interaction and mechanism of action: insights from experimental and molecular dynamics simulations studies. Frontiers in Pharmacology 12, article number: 731499. (10.3389/fphar.2021.731499)
- Shu Jeng Ting, D. et al. 2021. Hybrid derivative of cathelicidin and human beta defensin-2 against Gram-positive bacteria: A novel approach for the treatment of bacterial keratitis. Scientific Reports 11, article number: 18304. (10.1038/s41598-021-97821-3)
- Akhtar, R., Tahir, H., Stewart, E., Wei, R., Mohammed, I. and Amoaku, W. M. 2021. Toll-like receptor signalling pathways regulate hypoxic stress induced fibroblast growth factor but not vascular endothelial growth factor-a in human microvascular endothelial cells. International Journal of Translational Medicine 1(1), pp. 25-38. (10.3390/ijtm1010003)
- Mohammed, I., Kulkarni, B., Faraj, L. A., Abbas, A., Dua, H. S. and King, A. J. 2020. Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: a two-year randomised evaluation study. Clinical & experimental ophthalmology 48(7), pp. 973-982. (10.1111/ceo.13814)
- Mohammed, I. et al. 2020. Antimicrobial peptides in human corneal tissue of patients with fungal keratitis. British Journal of Ophthalmology 105, pp. 1172-1177. (10.1136/bjophthalmol-2020-316329)
- Ting, D. S. J., Beuerman, R. W., Dua, H. S., Lakshminarayanan, R. and Mohammed, I. 2020. Strategies in translating the therapeutic potentials of host defense peptides. Frontiers in Immunology 11, article number: 983. (10.3389/fimmu.2020.00983)
- Al-Aqaba, M. A., Dhillon, V. K., Mohammed, I., Said, D. G. and Dua, H. S. 2019. Corneal nerves in health and disease. Progress in Retinal and Eye Research 73, article number: 100762. (10.1016/j.preteyeres.2019.05.003)
- Mohammed, I., Said, D. G., Nubile, M., Mastropasqua, L. and Dua, H. S. 2019. Cathelicidin-derived synthetic peptide improves therapeutic potential of vancomycin against pseudomonas aeruginosa. Frontiers in Microbiology 10, article number: 2190. (10.3389/fmicb.2019.02190)
- Al-Aqaba, M. A., Anis, F. S., Mohammed, I., Yapa, A. D. S., Amoaku, W. M. and Dua, H. S. S. 2019. In vivo confocal microscopy features and clinicohistological correlation of limbal nerve corpuscles. British Journal of Ophthalmology 105, pp. 285-289. (10.1136/bjophthalmol-2018-313199)
- Ghoz, N., Ross, A. R., Mohammed, I., Hogan, E., Said, D. G. and Dua, H. S. 2019. Management of primary pterygium with intra-lesional injection of 5 flurouracil and bevacizumab (Avastin).. Eye 33, pp. 1776-1783. (10.1038/s41433-019-0493-0)
- Song, D. et al. 2019. Complement factor h mutation w1206r causes retinal thrombosis and ischemic retinopathy in mice. The American Journal of Pathology 189(4), pp. 826-838. (10.1016/j.ajpath.2019.01.009)
- Said, D. G., Ross, A. R., Messina, M., Mohammed, I. and Dua, H. S. 2018. Localised corneal haze and scarring following pulsed accelerated collagen cross-linking for keratoconus. Eye (Basingstoke) 33(1), pp. 167-168. (10.1038/s41433-018-0211-3)
- Song, D. et al. 2018. Retinal basal laminar deposits in complement fh/fp mouse model of dense deposit disease. Investigative Ophthalmology & Visual Science 54, pp. 3405-3415. (10.1167/iovs.18-24133)
- Mohammed, I., Ross, A. R., Britton, J. O., Said, D. G. and Dua, H. S. 2018. Elastin content and distribution in endothelial keratoplasty tissue determines direction of scrolling. American Journal of Ophthalmology 194, pp. 16-25. (10.1016/j.ajo.2018.07.001)
- Al-Aqaba, M. ., Anis, F. S., Mohammed, I. and Dua, H. S. 2017. Nerve terminals at the human corneoscleral limbus. British Journal of Ophthalmology 102(4), pp. 556-561. (10.1136/bjophthalmol-2017-311146)
- Mohammed, I., Said, D. G. and Dua, H. S. 2017. Human antimicrobial peptides in ocular surface defense. Progress in Retinal and Eye Research 61, pp. 1-22. (10.1016/j.preteyeres.2017.03.004)
- Ueda, Y. et al. 2017. Murine systemic thrombophilia and hemolytic uremic syndrome from a factor h point mutation. Blood 129(9), pp. 1184-1196. (10.1182/blood-2016-07-728253)
- Haris, M. et al. 2014. In vivo magnetic resonance imaging of tumor protease activity. Scientific Reports 4, article number: 6081. (10.1038/srep06081)
- Dua, H. S., Otri, A., Hopkinson, A. and Mohammed, I. 2014. In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American Ophthalmological Society thesis).. Transactions of the American Ophthalmological Society 112, pp. 50-73.
- Barata, L., Miwa, T., Sato, S., Kim, D., Mohammed, I. and Song, W. C. 2013. Deletion of crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack. The Journal of Immunology 190(6), pp. 2886-2895. (10.4049/jimmunol.1202536)
- Otri, A. M., Mohammed, I., Al-Aqaba, M. A., Fares, U., Peng, C., Hopkinson, A. and Dua, H. S. 2012. Variable expression of human beta defensins 3 and 9 at the human ocular surface in infectious keratitis. Investigative Ophthalmology and Visual Science 53(2), pp. 757-761. (10.1167/iovs.11-8467)
- Mohammed, I. et al. 2011. Increased expression of hepcidin and toll-like receptors 8 and 10 in viral keratitis. Cornea 30(8), pp. 899-904. (10.1097/ICO.0b013e31820126e5)
- Kulkarni, B., Mohammed, I., Hopkinson, A. and Dua, H. S. 2011. Validation of endogenous control genes for gene expression studies on human ocular surface epithelium. PLoS ONE 6(8), article number: 22301. (10.1371/journal.pone.0022301)
- Mohammed, I., Yeung, A., Abedin, A., Hopkinson, A. and Dua, H. S. 2011. Signalling pathways involved in ribonuclease-7 expression. Cellular and Molecular Life Sciences 68(11), pp. 1941-1952. (10.1007/s00018-010-0540-2)
- Mohammed, I., Suleman, H., Otri, A. M., Kulkarni, B. B., Chen, P., Hopkinson, A. and Dua, H. S. 2010. Localization and gene expression of human β-defensin 9 at the human ocular surface epithelium. Investigative Ophthalmology and Visual Science 51(9), pp. 4677-4682. (10.1167/iovs.10-5334)
- Kulkarni, B. B. et al. 2010. Comparative transcriptional profiling of the limbal epithelial crypt demonstrates its putative stem cell niche characteristics. BMC Genomics 11(1), article number: 526. (10.1186/1471-2164-11-526)
- Otri, A. M., Mohammed, I., Abedin, A., Cao, Z., Hopkinson, A., Panjwani, N. and Dua, H. S. 2010. Antimicrobial peptides expression by ocular surface cells in response to acanthamoeba castellanii: an in vitro study. British Journal of Ophthalmology 94(11), pp. 1523-1527. (10.1136/bjo.2009.178236)
- Gicquel, J. et al. 2009. Epidermal growth factor variations in amniotic membrane used for ex vivo tissue constructs. Tissue Engineering - Part A 15(8), pp. 1919-1927. (10.1089/ten.tea.2008.0432)
- Yeung, A., Tint, N., Kulkarni, B., Mohammed, I., Suleman, H., Hopkinson, A. and Dua, H. S. 2009. Infant limbus: an immunohistological study. Experimental Eye Research 88(6), pp. 1161-1164. (10.1016/j.exer.2008.12.014)
- Abedin, A., Mohammed, I., Hopkinson, A. and Dua, H. S. 2008. A novel antimicrobial peptide on the ocular surface shows decreased expression in inflammation and infection. Investigative Ophthalmology and Visual Science 49(1), pp. 28-33. (10.1167/iovs.07-0645)
Research
The main focus of my laboratory is to study the host-pathogen interactions during corneal infection, especially investigating the pathobiology resulting from the interaction of immune cells with bacterial biofilms in the cornea. In addition, our aim is to investigate the pharmacological efficacy and safety of synthetic host-defence peptides as an alternative therapy for the treatment of corneal infection.
We utilise a preclinical mouse model of corneal infection for studying the host-pathogen interactions and testing novel therapeutics. Also, appropriate in-vitro, ex-vivo, and in-silico model systems are well-established for initial safety screening and efficacy studies.
Potential for collaborations and hosting of fellowships:
My laboratory is open for academic/industrial collaborations and hosting potential postdoctoral/PhD fellowships in the following areas of research:
- Anti-infective agents: Development and testing
- Corneal infections: Dissecting disease pathology and testing novel therapeutics
- Antimicrobial resistance: Their relevance to the severity of disease and ineffectiveness of available therapeutics
- Anti-biofilm agents: Development and testing
- Host-pathogen interactions: mainly involved during microbial keratitis and biofilm infections
- Complement activation pathways: their dysregulation and association with corneal disease pathologies
- Host-defence peptides: Redesign, development, and testing
Current collaborators:
- Miguel Camara - Professor of Microbiology and Co-director of National Biofilms Innovation Centre (University of Nottingham)
- Arwyn Jones - Professor of Pharmacy and Pharmaceutical Sciences (Cardiff University)
- Polina Porkopovich - Reader of Pharmacy (Cardiff University)
- Oliver Castell - Reader of Pharmacy (Cardiff University)
- Luisa-Martinez Pomares - Professor of Immunology (University of Nottingham)
- Harminder S. Dua - Head and Professor of Ophthalmology (University of Nottingham)
- Winfried M. Amoaku - Associate Professor of Ophthalmology (University of Nottingham)
- Naing Latt Tint - Consultant Ophthalmologist (University of Edinburgh)
- Beth Mills - UKRI Future Leader Fellow (University of Edinburgh)
- Chandra Verma - Senior Principal Investigator (A*Star Bioinformatics Institute, Singapore)
- Rajamani Lakshminarayanan - Head and Principal Investigator (Singapore Eye Research Institute, Singapore)
- Wen-Chao Song - Professor of Pharmacology (University of Pennsylvania, USA)
Teaching
Undergraduate Teaching
Module/s | Course and Organisation | Role | Years |
The Human Body and Mind (OP4003) |
Master of Optometry (MOptom) program (Preliminary year) School of Optometry and Vision Sciences, Cardiff University, UK |
Module leader and lecturing | 2023 - present |
Patients Health and Disease (OP4103) |
Master of Optometry (MOptom) program (1st year) School of Optometry and Vision Sciences, Cardiff University, UK |
Lead practical sessions | 2023 - present |
Ocular Pharmacology (OP2205) |
BSc Optometry and Vision Sciences program (2nd year) School of Optometry and Vision Sciences, Cardiff University, UK |
Co-supervision of practical sessions | 2022 - present |
Research in Optometry and Vision Sciences (OP3207) |
BSc Optometry and Vision Sciences program (3rd year) School of Optometry and Vision Sciences, Cardiff University, UK |
Lead research projects | 2022 - present |
Research Project (OPT063) |
MSc Optometry program (Full-time and Part-time courses) School of Optometry and Vision Sciences, Cardiff University, UK |
Lead research projects | 2022 - present |
Studying science and skills (OP0306) |
BSc Optometry and Vision Sciences program (1st year) School of Optometry and Vision Sciences, Cardiff University, UK |
Module leader and lecturing | 2022 - 23 |
From Cells to Systems (OP1205) |
BSc Optometry and Vision Sciences program (1st year) School of Optometry and Vision Sciences, Cardiff University, UK |
Co-supervision of practical sessions | 2022 - 23 |
Introduction to Sensory Neurosciences (A13ISN) |
BMedSci/MB BCh program (3rd year) School of Medicine, University of Nottingham, UK |
Selected lecturing each semester | 2017 - 22 |
General Immunology (PHG 218) Molecular Pharmacology (PHG 225) |
PharmD program (2nd year) College of Pharmacy, Qassim University, KSA |
Module leader and lecturing | 2014 - 15 |
Biography
Biography
Imran obtained an undergraduate qualification in Pharmacy (B.Pharm., with Distinction) from the Jawaharlal Nehru Technological University, Hyderabad, India. He moved to the UK for postgraduation and in 2005 completed an M.Sc. in Pharmacology (with Merit class) from Sheffield Hallam University, where he learnt the potential of biomedical research for drug discovery. His first research position as a Research Assitant at the University of Nottingham (UoN) was successful and led him to pursue a career in medical research. In 2006, Imran was awarded a Ph.D. studentship grant by the Fight for Sight (an eye research charity organisation) for doctoral studies at UoN under the supervision of Professor Harminder S. Dua and Dr. Andy Hopkinson. In April 2010, he was awarded a Ph.D. degree with a prestigious "Andrew Hendry Endowed Postgraduate Research Prize" for research excellence. Imran was keen to acquire specialised skills relevant to developing and studying preclinical murine model systems of ocular diseases, which led him to the USA. He completed Postdoctoral training (2010 to 2014) in the laboratory of Professor Wen-Chao Song at the University of Pennsylvania (UPenn), Philadelphia, PA, where he was awarded a prestigious "Biomedical Postdoctoral Prize" for research achievements. Between 2014 to 2015, Imran briefly explored a teaching position at Qassim University, KSA as an Assistant Professor of Immunology. Later in 2015, he was offered an eponymous position at Nottingham to work as an Elizabeth C. King senior scientist. Because of his continuous success at securing grant funding and publishing high-impact research articles, in 2018, he was promoted to an independent Senior Research Fellow post. In 2022, Imran joined Cardiff University (CU) as a Lecturer/Assistant Professor in the School of Optometry and Vision Sciences, where his laboratory investigates the immunopathology of corneal infection with a key interest in the development of synthetic host defence peptides as a novel therapy for its treatment.
Educational and Professional Qualifications
Qualification | Major | Dates |
Doctor of Philosophy (Ph.D.) University of Nottingham, UK | Ocular Immunology | 11/2006 – 04/2010 |
Master of Science (M.Sc.) Sheffield Hallam University, UK | Pharmacology and Biotechnology | 10/2004 - 09/2005 |
Bachelor of Pharmacy (B.Pharm.) Jawaharlal Nehru Technological University, India | Pharmacy | 10/1999 - 09/2003 |
Honours and awards
- Founders Cup for Best Research - 103rd Oxford Ophthalmological Congress (2019)
- PDPR appraisal rating #1 – University of Nottingham (2017)
- Poster First Prize – 21st Nottingham Eye Symposium (2017)
- Elizabeth C. King eponymous Research Fellowship – University of Nottingham (2015)
- AUM Life-Tech Postdoctoral Award - University of Pennsylvania (2013)
- Nottingham First Prize - 14th Nottingham Eye Symposium (2010)
- Andrew Hendry Endowed Post-Graduate Award - University of Nottingham (2010)
- First Prize - 1st Translational Research Day - University of Nottingham (2009)
- David Meyer Research Prize - 13th Nottingham Eye Symposium (2009)
- Best Scientific Paper Award – Asia-ARVO meeting (2009)
- Travel Fellowship Award – Asia-ARVO meeting (2009)
- Graduate School Travel Award - University of Nottingham (2009)
- Merit – MSc programme; Sheffield Hallam University (2005)
- Distinction – B. Pharm programme; JNT University (2003)
- Distinction – Board of Intermediate Education, Hyderabad (1998)
- Distinction – Board of Secondary Education, Hyderabad (1996)
Professional memberships
a) Academic / professional membership:
- British Society for Immunology (2021 – present)
- Oxford Ophthalmological Society (2019 – present)
- School Research Review Committee – University of Nottingham (2018 – 2022)
- School Safety Committee – University of Nottingham (2017 – 2022)
- School Mentorship Scheme – University of Nottingham (2017 – 2022)
- British Infection Association (2016 – present)
- International Complement Society (2010 – 2014)
- Biomedical Postdoctoral Association, University of Pennsylvania (2010 – 2014)
- Society of Mucosal Immunology (2009 – 2011)
- Association for Research in Vision and Ophthalmology (2008 – present)
- American Association for the Advancement of Science (2007 – 2008)
b) Licensure:
- Home Office Animal Project License Holder (PPLh), UK
- Home Office Animal Personal License (PIL A+B), UK
- Licensed User – Institutional Animal Care & Use Committee, University of Pennsylvania, USA
- Registered Pharmacist – Telangana State Pharmacy Council, India
Academic positions
Years | Position | Organisation |
2022 - present | Lecturer (Assistant Professor) | School of Optometry & Vision Sciences, Cardiff University, UK |
2018 - 2022 | Senior Research Fellow | Academic Ophthalmology, University of Nottingham, UK |
2015 - 2018 | Elizabeth C. King Senior Research Scientist | Academic Ophthalmology, University of Nottingham, UK |
2014 - 2015 | Assistant Professor (teaching track) | College of Pharmacy, Qassim University, KSA |
2010 - 2014 | Postdoctoral Researcher | School of Medicine, University of Pennsylvania, USA |
2006 - 2010 | PhD Scholar | Div of Ophthalmology & Visual Sciences, University of Nottingham, UK |
2005 - 2006 | Research Assistant | Div of Ophthalmology & Visual Sciences, University of Nottingham, UK |
Committees and reviewing
Journal editorial board: |
|
Reviewing for grant bodies |
|
Reviewing for scientific journals: |
|
Supervisions
I am interested in supervising PhD students in the areas of:
- Antimicrobial peptides (Host-defence peptides): Development and testing in ex-vivo and in-vivo model systems
- Developing alternative therapies to combat Antimicrobial resistance (AMR)
- Novel therapies for the management of corneal infection (microbial keratitis)
- Anti-biofilm agents
- Studying pathobiology of microbial keratitis: Investigating the role of complement activation pathways in disease severity
Research themes
Specialisms
- Infectious diseases
- Antimicrobial resistance
- Innate immunity
- Drug development
- Drug delivery